BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 15147180)

  • 81. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis.
    Jennings C; West J; Waine C; Craik D; Anderson M
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10614-9. PubMed ID: 11535828
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Analysis and classification of circular proteins in CyBase.
    Kaas Q; Craik DJ
    Biopolymers; 2010; 94(5):584-91. PubMed ID: 20564021
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Fmoc-based synthesis of disulfide-rich cyclic peptides.
    Cheneval O; Schroeder CI; Durek T; Walsh P; Huang YH; Liras S; Price DA; Craik DJ
    J Org Chem; 2014 Jun; 79(12):5538-44. PubMed ID: 24918986
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Divalent cation coordination and mode of membrane interaction in cyclotides: NMR spatial structure of ternary complex Kalata B7/Mn2+/DPC micelle.
    Shenkarev ZO; Nadezhdin KD; Lyukmanova EN; Sobol VA; Skjeldal L; Arseniev AS
    J Inorg Biochem; 2008; 102(5-6):1246-56. PubMed ID: 18295894
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Progress in kalata peptide production via plant cell bioprocessing.
    Dörnenburg H
    Biotechnol J; 2009 May; 4(5):632-45. PubMed ID: 19452465
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Discovery, structure and biological activities of cyclotides.
    Daly NL; Rosengren KJ; Craik DJ
    Adv Drug Deliv Rev; 2009 Sep; 61(11):918-30. PubMed ID: 19470399
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins.
    Heitz A; Hernandez JF; Gagnon J; Hong TT; Pham TT; Nguyen TM; Le-Nguyen D; Chiche L
    Biochemistry; 2001 Jul; 40(27):7973-83. PubMed ID: 11434766
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In Planta Discovery and Chemical Synthesis of Bracelet Cystine Knot Peptides from
    Dang TT; Chan LY; Tombling BJ; Harvey PJ; Gilding EK; Craik DJ
    J Nat Prod; 2021 Feb; 84(2):395-407. PubMed ID: 33570395
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Circling the enemy: cyclic proteins in plant defence.
    Craik DJ
    Trends Plant Sci; 2009 Jun; 14(6):328-35. PubMed ID: 19423383
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Elucidating the structure of two cyclotides of Viola tianshanica maxim by MALDI TOF/TOF MS analysis].
    Xiang B; Du GH; Wang XC; Zhang SX; Qin XY; Kong JQ; Cheng KD; Li YJ; Wang W
    Yao Xue Xue Bao; 2010 Nov; 45(11):1402-9. PubMed ID: 21361040
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2.
    Leta Aboye T; Clark RJ; Craik DJ; Göransson U
    Chembiochem; 2008 Jan; 9(1):103-13. PubMed ID: 18058973
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Solution structure of the cyclotide palicourein: implications for the development of a pharmaceutical framework.
    Barry DG; Daly NL; Bokesch HR; Gustafson KR; Craik DJ
    Structure; 2004 Jan; 12(1):85-94. PubMed ID: 14725768
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A systematic approach to document cyclotide distribution in plant species from genomic, transcriptomic, and peptidomic analysis.
    Gerlach SL; Göransson U; Kaas Q; Craik DJ; Mondal D; Gruber CW
    Biopolymers; 2013 Sep; 100(5):433-7. PubMed ID: 23907794
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Circular proteins from Melicytus (Violaceae) refine the conserved protein and gene architecture of cyclotides.
    Trabi M; Mylne JS; Sando L; Craik DJ
    Org Biomol Chem; 2009 Jun; 7(11):2378-88. PubMed ID: 19462049
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Host-defense activities of cyclotides.
    Craik DJ
    Toxins (Basel); 2012 Feb; 4(2):139-56. PubMed ID: 22474571
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cyclotide-membrane interactions: defining factors of membrane binding, depletion and disruption.
    Burman R; Strömstedt AA; Malmsten M; Göransson U
    Biochim Biophys Acta; 2011 Nov; 1808(11):2665-73. PubMed ID: 21787745
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cyclotide isolation and characterization.
    Craik DJ; Henriques ST; Mylne JS; Wang CK
    Methods Enzymol; 2012; 516():37-62. PubMed ID: 23034223
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The cyclotides: novel macrocyclic peptides as scaffolds in drug design.
    Craik DJ; Simonsen S; Daly NL
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):251-60. PubMed ID: 11926131
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Semienzymatic cyclization of disulfide-rich peptides using Sortase A.
    Jia X; Kwon S; Wang CA; Huang YH; Chan LY; Tan CC; Rosengren KJ; Mulvenna JP; Schroeder CI; Craik DJ
    J Biol Chem; 2014 Mar; 289(10):6627-6638. PubMed ID: 24425873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.